These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23457619)

  • 21. Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor alpha-induced apoptosis and activation of caspase-8 and -3.
    Al-Zoubi AM; Efimova EV; Kaithamana S; Martinez O; El-Idrissi Mel-A; Dogan RE; Prabhakar BS
    J Biol Chem; 2001 Dec; 276(50):47202-11. PubMed ID: 11577081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer.
    Zhou Z; Liu R; Chen C
    Int J Cancer; 2012 Apr; 130(7):1504-10. PubMed ID: 21480222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DENN/MADD/IG20 alternative splicing changes and cell death in Alzheimer's disease.
    Mo Y; Williams C; Miller CA
    J Mol Neurosci; 2012 Sep; 48(1):97-110. PubMed ID: 22678883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening.
    Garimella SV; Gehlhaus K; Dine JL; Pitt JJ; Grandin M; Chakka S; Nau MM; Caplen NJ; Lipkowitz S
    Breast Cancer Res; 2014 Apr; 16(2):R41. PubMed ID: 24745479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
    Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
    Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.
    Das S; Tripathi N; Siddharth S; Nayak A; Nayak D; Sethy C; Bharatam PV; Kundu CN
    Apoptosis; 2017 Oct; 22(10):1205-1224. PubMed ID: 28702823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells.
    Haag C; Stadel D; Zhou S; Bachem MG; Möller P; Debatin KM; Fulda S
    Gut; 2011 Feb; 60(2):225-37. PubMed ID: 20876774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRAIL therapy in non-small cell lung cancer cells: sensitization to death receptor-mediated apoptosis by proteasome inhibitor bortezomib.
    Voortman J; Resende TP; Abou El Hassan MA; Giaccone G; Kruyt FA
    Mol Cancer Ther; 2007 Jul; 6(7):2103-12. PubMed ID: 17620439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Meslin F; Hamaï A; Gao P; Jalil A; Cahuzac N; Chouaib S; Mehrpour M
    Cancer Res; 2007 Nov; 67(22):10910-9. PubMed ID: 18006836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroids.
    Chandrasekaran S; Marshall JR; Messing JA; Hsu JW; King MR
    PLoS One; 2014; 9(10):e111487. PubMed ID: 25343626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of RIP1 by 2-deoxy-D-glucose sensitizes breast cancer cells to TRAIL-induced apoptosis.
    Huang YY; Liu H; Li Y; Pu LJ; Jiang CC; Xu JC; Jiang ZW
    Eur J Pharmacol; 2013 Apr; 705(1-3):26-34. PubMed ID: 23499682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of IG20 splice variants in TRAIL resistance.
    Prabhakar BS; Mulherkar N; Prasad KV
    Clin Cancer Res; 2008 Jan; 14(2):347-51. PubMed ID: 18223207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.
    Fandy TE; Shankar S; Srivastava RK
    Mol Cancer; 2008 Jun; 7():60. PubMed ID: 18590557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder.
    Schneeberger PE; Kortüm F; Korenke GC; Alawi M; Santer R; Woidy M; Buhas D; Fox S; Juusola J; Alfadhel M; Webb BD; Coci EG; Abou Jamra R; Siekmeyer M; Biskup S; Heller C; Maier EM; Javaher-Haghighi P; Bedeschi MF; Ajmone PF; Iascone M; Peeters H; Ballon K; Jaeken J; Rodríguez Alonso A; Palomares-Bralo M; Santos-Simarro F; Meuwissen MEC; Beysen D; Kooy RF; Houlden H; Murphy D; Doosti M; Karimiani EG; Mojarrad M; Maroofian R; Noskova L; Kmoch S; Honzik T; Cope H; Sanchez-Valle A; ; Gelb BD; Kurth I; Hempel M; Kutsche K
    Brain; 2020 Aug; 143(8):2437-2453. PubMed ID: 32761064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IG20/MADD plays a critical role in glucose-induced insulin secretion.
    Li LC; Wang Y; Carr R; Haddad CS; Li Z; Qian L; Oberholzer J; Maker AV; Wang Q; Prabhakar BS
    Diabetes; 2014 May; 63(5):1612-23. PubMed ID: 24379354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species.
    Yodkeeree S; Sung B; Limtrakul P; Aggarwal BB
    Cancer Res; 2009 Aug; 69(16):6581-9. PubMed ID: 19654295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.